ArticleFrontiers in oncology2024

External validation of hemoglobin and neutrophil levels as predictors of the effectiveness of ipilimumab plus nivolumab for treating renal cell carcinoma.

Shuzo Hamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.